M6P Therapeutics Email Format

Biotechnology ResearchMissouri, United States11-50 Employees

M6P Therapeutics operates in the biotechnology research sector, focusing on therapies for lysosomal storage disorders. The company has identified a method to substantially increase the phosphorylation of mannose-6-phosphate on various lysosomal enzymes, with the aim of improving enzyme delivery to affected tissues and potentially enhancing clinical outcomes. By pursuing enzyme replacement and gene therapies, the firm seeks to address core treatment challenges in LSDs.

Based in St. Louis, Missouri, it is a small to mid-sized biotechnology company. Its work centers on developing therapies for LSDs that rely on improved enzyme targeting to tissues, addressing delivery barriers in current approaches. A recent development includes presenting preclinical data at the WORLDSymposium in February 2023, reflecting progress in its research program.

Sign up for free to view info

Company overview Employee directory